Bristol Myers Squibb Integrates NVIDIA AI to Strengthen Cancer R&D, BMY Stock Up 1.28%
Bristol Myers Squibb (NYSE: BMY) stock closed at $60.93 on July 21, up 1.28% on the day. The previous day, the company announced the integration of NVIDIA’s DGX SuperPOD (with the DGX Vera Rubin NVL72 system) to enhance its AI capabilities, aiming to advance research programs in oncology and immunology. Bristol Myers Squibb and NVIDIA DGX SuperPOD Partnership Announcement Based on market data for July 21, 2026, BMY stock closed at $60.93, up 1.28% from the prior trading day. The day before (July
MarketWhisper·07-22 01:48





